Morris M, Devynck M A, Pernollet M G, Meyer P
INSERM U 7, département de pharmacologie, hôpital Necker, Paris, France.
Arch Mal Coeur Vaiss. 1988 Jun;81 Spec No:105-8.
Atrial natriuretic peptide (ANP) and Na+ pump inhibitor (digitalis-like substance, DLS) have both been proposed to participate in body sodium and water homeostasis. Plasma levels and ANP and DLS have been reported to be increased in physiological or pathological states characterized by volume expansion. In order to investigate possible mutual relationships, their concentrations were measured in parallel during acute volume expansion by injection of 25 ml/kg isotonic NaCl (A) or blood (B) in the conscious rat. ANP was measured by radioimmunoassay and DLS by inhibition of renal Na+, K+-ATPase activity and digoxin-like immunoreactivity (DLI). Five minutes after injection, plasma ANP increased to reach 700 pg/ml (A, n = 21) or 1,500 pg/ml (B, n = 5) but the ability of plasma extracts to inhibit the renal Na+, K+-ATPase activity was unchanged (16.6 +/- 2.5 vs 16.9 +/- 2.0 p. 100, A, n = 8 and 6). Digoxin-like immunoreactivity was slightly lowered after NaCl injection from (74.4 +/- 6.2 to 65.4 +/- 5.1 pg/ml, n = 21) and unchanged after blood injection (79.0 +/- 3.4 vs 81.2 +/- 5.0 pg/ml, n = 5). Plasma ANP concentrations then decreased and had returned to preinjection values before 30 (A) or 90 (B) minutes, whereas the capacity of plasma to inhibit the Na+, K+-ATPase tended to increase (25.9 +/- 4.7 p. 100 at 3 hours after injection, n = 12 compared to 17.6 +/- 1.6 p. 100, n = 20) and DLI remains stable.(ABSTRACT TRUNCATED AT 250 WORDS)
心房利钠肽(ANP)和钠泵抑制剂(洋地黄样物质,DLS)均被认为参与机体钠和水平衡。据报道,在以容量扩张为特征的生理或病理状态下,血浆中ANP和DLS水平会升高。为了研究它们之间可能的相互关系,在清醒大鼠中通过注射25 ml/kg等渗氯化钠(A)或血液(B)进行急性容量扩张期间,并行测量了它们的浓度。通过放射免疫测定法测量ANP,通过抑制肾钠钾ATP酶活性和地高辛样免疫反应性(DLI)来测量DLS。注射后5分钟,血浆ANP升高至700 pg/ml(A组,n = 21)或1500 pg/ml(B组,n = 5),但血浆提取物抑制肾钠钾ATP酶活性的能力未改变(分别为16.6±2.5对16.9±2.0 p. 100,A组,n = 8和6)。注射氯化钠后,地高辛样免疫反应性略有降低(从74.4±6.2降至65.4±5.1 pg/ml,n = 21),注射血液后则无变化(79.0±3.4对81.2±5.0 pg/ml,n = 5)。然后血浆ANP浓度下降,并在30分钟(A组)或90分钟(B组)前恢复到注射前值,而血浆抑制钠钾ATP酶的能力趋于增加(注射后3小时为25.9±4.7 p. 100,n = 12,相比之下,n = 20时为17.6±1.6 p. 100),且DLI保持稳定。(摘要截取自250字)